In this issue of Blood, Flinn et al, Kahl et al, and Brown et al provide further encouragement that the possibility of a chemotherapy-free world is, indeed, a rapidly approaching reality in indolent non-Hodgkin lymphomas (NHLs), mantle cell lymphoma (MCL), and chronic lymphocytic leukemia (CLL). © 2014 by The American Society of Hematology.
CITATION STYLE
Cheson, B. D. (2014, May 29). CLL and NHL: The end of chemotherapy? Blood. American Society of Hematology. https://doi.org/10.1182/blood-2014-04-563890
Mendeley helps you to discover research relevant for your work.